Zepbound’s common side effects include digestive issues (such as nausea or vomiting), injection site reactions, and abdominal pain. Serious side effects of Zepbound include severe digestive issues, ...

Lupron Depot (leuprolide acetate) is a brand-name injection prescribed for prostate cancer and other hormone-related conditions. Lupron Depot’s side effects may vary depending on the dosage and the ...

EpiPen contains epinephrine, a lifesaving medication for severe allergic reactions (anaphylaxis). Common side effects include fast heartbeat, tremor, dizziness, anxiety, and nausea, which typically ...

Many injectable peptides are unregulated and have not been reviewed for safety by the FDA. Users have reported side effects such as injection site reactions, fatigue, headaches, and gastrointestinal ...

The most common side effects you may experience with Mounjaro include nausea, vomiting, diarrhea, constipation, and stomach pain. These side effects typically go away on their own within a few weeks ...

By Nancy Lapid May 6 (Reuters) - An experimental drug from Revolution Medicines that nearly doubled survival time for patients with advanced pancreas cancer in clinical trials comes with a high rate ...

Kristie Reed, PharmD, oversees emergency, general medical, surgical, psychiatric care, and oncology medication as the pharmacy director of a community hospital. Dr. Reed specializes in IV medications.

Kirstyn Hill has worked as a clinical pediatric and women’s health pharmacist since 2020. She was driven to work with a patient population that is not often able to easily speak up for themselves and ...

Botox-A may provide a slight short-term improvement in pain (6%) which does not extend to the long term. People may report treatment success (20%) in both the short and long term. There may be no ...

It’s tough to avoid the current hype about the health benefits of injecting peptides. Although these substances – essentially, synthetic bits of protein in solution – have long made the rounds in the ...

The FDA has approved golimumab-sldi as the first interchangeable biosimilar to Simponi for ulcerative colitis. Golimumab-sldi ...